Park, S.Y., et al., Effects of foot complications in patients with Type 2 diabetes mellitus on public healthcare: An analysis based on the Korea National Diabetes Program Cohort. J Diabetes Complications, 2017. 31(2): p. 375-380.
 Hollingworth, S.A., et al., Impact of a general practitioner-led integrated model of care on the cost of potentially preventable diabetes-related hospitalisations. Prim Care Diabetes, 2017. 11(4): p. 344-347.
 Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017; 128: 40–50.
 Xu J, Xu L, Wang YX, You QS, Jonas JB, Wei WB. Tenyear cumulative incidence of diabetic retinopathy. The Beijing Eye Study 2001/2011. PLoS One 2014; 9: e111320.
 Wong TY, Sun J, Kawasaki R, Ruamviboonsuk P, Gupta N, Lansingh VC, Maia M, Mathenge W, Moreker S, Muqit MMK, Resnikoﬀ S, Verdaguer J, Zhao P, Ferris F, Aiello LP, Taylor HR. Guidelines on diabetic eye care: the International Council of Ophthalmology Recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology 2018;125:1608-22.
 Solomon SD, Chew E, Duh EJ, Sobrin L, Sun JK, VanderBeek BL, Wykoﬀ CC, Gardner TW. Diabetic retinopathy: a position statement by the American Diabetes Association. Diabetes Care 2017;40:412-8.
 Hendrick, A.M., M.V. Gibson, and A. Kulshreshtha, Diabetic Retinopathy. Prim Care, 2015. 42(3): p. 451-64.
 International Diabetes Federation (IDF). The global burden. [article online]. 2014. http://www.idf.org/diabetesatlas/5e/the-globalburden. Accessed 18 Dec 2014.
 Sabanayagam, C., et al., Incidence and progression of diabetic retinopathy: a systematic review. Lancet Diabetes Endocrinol, 2018
 Wong, T.Y., et al., Diabetic retinopathy. Nat Rev Dis Primers, 2016. 2: p. 16012.
 Henricsson M, Nystrom L, Blohme G, et al. The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care 2003; 26: 349–54.
 Bressler NM, Edwards AR, Beck RW, et al. Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial. JAMA Ophthalmol 2013;131(8):1033–40.
 Kusuhara, S., et al., Pathophysiology of Diabetic Retinopathy: The Old and the New. Diabetes Metab J, 2018. 42(5): p. 364-376.
 Two-year course of visual acuity in severe proliferative diabetic retinopathy with conventional management. Diabetic Retinopathy Vitrectomy Study (DRVS) report #1. Ophthalmology 1985;92(4):492–502.
 Kahm, K., et al., Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany. Diabetes Care, 2018. 41(5): p. 971-978.
 National Health and Family Planning Commission of the People’s Republic of China. China’s Health and Family Planning Statistics Yearbook 2016. Beijing: China Union Medical University Press, 2016.